Thursday, February 28, 2019

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Maintains Lofty Growth Expectations for 2019


  • The Green Organic Dutchman is building on a series of agreements to scale up its cannabis production operations in Canada, Jamaica, Europe and Latin America
  • The Company’s first crop goes on sale soon to an exclusive loyalty group of patients and investors
  • The Dutchman’s production strategy envisions 80,000 kilograms of cultivation by the end of this year en route to 219,000-kilogram buildout by 2021
  • The company’s focus is on a premium organic brand built to high standards of environmental friendliness
Canada’s prime mover efforts to legalize the use of cannabis nationwide, not only as a medicinal substance but also as a wellness-enhancing consumable and a recreational drug, has made it a fertile field for entrepreneurial innovation and a friend to innovative business operations such as The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) – an Ontario-based producer of 100 percent-certified organic cannabis with an expanding footprint.

The Green Organic Dutchman, also known simply by its ticker, ‘TGOD’, was described by cannabis news outlet The Motley Fool last year as one of Canada’s top seven marijuana growers, thanks largely to the company’s plans to produce some 200,000 kilograms (about 440,000 pounds) in annual yield when it reaches full capacity. While construction of its almost 1.7 million square feet of cultivation facilities across Ontario, Quebec, and Jamaica (http://ibn.fm/YjquT) continues, TGOD has been cultivating in Ontario on a small scale since 2016 and began delivering its first commercial crop to an exclusive loyalty pool of patients and investors this month (http://ibn.fm/FDD5c).

The first phase of construction at the Ontario site is expected to be complete during the second quarter of this year, establishing an enclosed facility capable of producing 2,000 kilograms of cannabis. The company will then continue, with a hybrid facility capable of 14,500 kilograms expected to be completed in Q2 as well. At the Quebec site, which will reach 185,000 kilograms of organic cannabis at buildout, the first cultivation is expected in the fourth quarter of this year.

When the company’s purpose-built hybrid greenhouses are complete, they will stand as a testament to the Dutchman’s commitment to minimizing its environmental impact. They are expected to be among the largest LEED (Leadership in Energy and Environmental Design) system-certified facilities in the world and will also be completed to European Union good manufacturing practice (“eGMP”) standards in anticipation of expansion into that market.

TGOD has chosen to reject irradiation of its product — a process that can extend the shelf life of foods, but also one that adversely affects the terpenes in cannabis that are responsible for scent and flavor. Likewise, the company uses carbon dioxide rather than solvents or additives to extract oils from cannabis with minimal environmental impact.

Earlier this month, TGOD announced an agreement to supply cannabis to the Ontario Cannabis Retail Corporation (“OCRC”), the latest in a series of ventures that include product distribution in Denmark, Jamaica, Mexico and Poland. The OCRC is the only legal online store for recreational cannabis in Ontario and will also become the provincial wholesaler of cannabis for private retail stores once the regulatory framework is in place this spring.

A run-rate timeline published by the company shows that it expects to go from producing over 20,000 kilograms of cannabis by the third quarter of this year to more than 80,000 kilograms by the fourth quarter, and then to 219,000 kilograms by the third quarter of 2021 (http://ibn.fm/QTjgn).

TGOD’s agreement with global power management company Eaton Corp. is also enabling it to increase its revenue margins, because Eaton is providing TGOD with some of the lowest electricity input costs in the business as part of a research and optimization project that Eaton is using to advance its profile in cannabis growing power management and lighting on a global scale. The agreement is one more example of the Dutchman’s foresight in executing productive partnerships to establish a low-cost, high-quality product that will benefit the consumer.

For more information, visit the company’s website at www.TGOD.ca

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html


MissionIRNewsBreaks – Cannabis Strategic Ventures Inc. (NUGS) Carves Out Additional Section of Communities in California for Cannabis Cultivation


Cannabis industry incubator Cannabis Strategic Ventures (OTC: NUGS) is preparing cultivation sites in California from San Francisco to Los Angeles. A recent article discussing the company reads, “Drive 400 miles from San Francisco to Los Angeles anytime soon, and you may be passing through Cannabis Strategic Ventures Inc. (OTC: NUGS) land. The Golden State incubator and brand builder is set to benefit from a large batch of licenses awarded in cannabis-friendly communities along the stretch. Recently, NUGS announced that it had signed a letter of intent to partner with a Santa Barbara County grow operation that holds approximately 40 commercial cannabis licenses from the County of Santa Barbara, the California Bureau of Cannabis Control, the Manufactured Cannabis Safety Branch and the CalCannabis Cultivation (http://ibn.fm/b28rQ). This impending deal signals NUGS’ commitment to its strategy of promoting brands to be category leaders in the recreational and medical cannabis sectors. The NUGS management team believes that the cultivation sites will eventually be a critical component of each brand’s supply chain.”

To view the full article, visit http://ibn.fm/ois2n

About Cannabis Strategic Ventures Inc.

Cannabis Strategic Ventures is a Los Angeles-based firm that incubates, develops and partners with category leaders within the cannabis sector. The firm’s NUGS brand experience provides mentorship and a range of essential services to emerging and existing cannabis consumer brands. The company recently completed a name and symbol change from Cascade Energy Inc. Cannabis Strategic Ventures is publicly traded on the U.S. Over-the-Counter Market with the stock symbol NUGS. For more information, visit the company’s website at www.CannabisStrategic.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html


MissionIRNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Releases Q3 Financial Highlights and Corporate Update


Dynamic plant-based food and beverage company Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) on Wednesday released its financial results for the three and nine months ended December 31, 2018. Per the update, Canopy Rivers’ full Management’s Discussion and Analysis (“MD&A”) and unaudited interim consolidated financial statements for the period are available on its SEDAR profile at www.SEDAR.com and via the company’s website. “With more than $55 million of capital deployed during the quarter, Canopy Rivers continues to position itself as a preeminent investment firm in the cannabis industry,” RIV Chief Financial Officer Eddie Lucarelli said in the news release. “As we continue to see meaningful developments at our portfolio companies, the closing of our bought deal financing and strategic investment from Canopy Growth will add additional strength to our balance sheet. With a strong pipeline of investment opportunities and regulatory reform continuing around the world, Canopy Rivers is optimally positioned to continue to prudently deploy capital to the global cannabis sector.”

To view the full press release, visit http://ibn.fm/0VlKC

About Canopy Rivers Inc.

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers works collaboratively with Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) to identify strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem. For more information, visit the company’s website at www.CanopyRivers.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html


Wednesday, February 27, 2019

MissionIRNewsBreaks – Net Element Inc.’s (NASDAQ: NETE) Unified Payments Subsidiary Achieves ETA Self-Regulation Certification

Global technology and value-added solutions group Net Element Inc. (NASDAQ: NETE) this morning announced that its Unified Payments subsidiary is among the first companies to achieve self-regulatory certification from the Electronic Transactions Association (“ETA”). The ETA, a worldwide trade association serving more than 500 member fintech payment companies, recently announced its Self-Regulation Program (“ETA SRP”), which seeks to improve payment industry security and reduce risks by identifying and acknowledging companies with a deep understanding of the risks associated with financial services. “Being among the first payments services companies to obtain ETA SRP certification is a reflection of our commitment to excellence in our industry,” Net Element Head of Risk Shawn Brown said in the news release. “We are pleased to support this program which assures our customers and stakeholders of our dedication to utilizing best practices in every facet of our company.”
To view the full press release, visit http://ibn.fm/4Y5kz
About Net Element
Net Element, Inc. (NASDAQ: NETE) operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the U.S. and selected emerging markets. In the U.S., it aims to grow transactional revenue by innovating SME productivity services using blockchain technology solutions and Aptito, the company’s cloud based, restaurant and retail point-of-sale solution. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500. In 2017, Net Element was recognized by South Florida Business Journal’s as one of 2016’s fastest growing technology companies. Further information is available at www.NetElement.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Youngevity International Inc. (NASDAQ: YGYI) Announces Expansion of Café Cachita Brand

Leading omni-direct lifestyle company Youngevity International Inc. (NASDAQ: YGYI) this morning announced the expansion of its recently acquired Café Cachita brand of espresso into over 500 retail locations through Southeastern Grocers. Per the update, the new distribution footprint will include all Winn Dixie, Bi-Lo, Fresco Y Mas and Harvey Stores across Florida, Georgia, Alabama, Louisiana, Mississippi, North Carolina and South Carolina. “Café La Rica is really beginning to gain traction.  Our foot print in Florida and the Southeast has been growing steadily and this is beginning to have a ripple effect into the West Coast and the Northeast as these geographical regions are beginning to support our brand,” Dave Briskie, president and CFO of YGYI, stated in the news release. “Our strategy of adding Café Cachita to our brand portfolio is designed to command more shelf space in the espresso category at retail. We appreciate the early success.”
To view the full press release, visit http://ibn.fm/RlxTy
About Youngevity International, Inc.
Youngevity International, Inc. is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that also offers e-commerce and the power of social selling. Assembling a virtual Main Street of products and services under one corporate entity, Youngevity offers proven products from the six top-selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, as well as innovative services. The company was formed during the summer 2011 merger of Youngevity Essential Life Sciences with Javalution Coffee Company (now part of the company’s food and beverage division). The resulting company became Youngevity International, Inc. in July 2013. For more information, visit the company’s website at www.YGYI.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Tuesday, February 26, 2019

MissionIRNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Supports Recent FDA Statement on Novel Nicotine Replacement Therapies


Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) this morning conveyed its support for the Food & Drug Administration’s (“FDA”) February 21 statement titled “Smoking Cessation and Related Indications: Developing Nicotine Replacement Therapy Drug Products”. The FDA’s statement outlined the development of safe and effective novel nicotine replacement therapies to help smokers quit cigarettes, stating that “novel products with different characteristics or routes of nicotine delivery have the potential to offer additional opportunities for health-concerned smokers interested in quitting.” Lexaria recently entered a partnership with a leading tobacco company to use DehydraTECH(TM) technology to develop new oral nicotine products. This technology could provide a nicotine delivery method that harmonizes with current FDA policies while avoiding the grave health consequences related to smoking cigarettes and preserving the consumers’ choice.

To view the full FDA statement, visit http://ibn.fm/4RIy8

To view the full press release, visit http://ibn.fm/eC8YC

About Lexaria Bioscience Corp.

Lexaria Bioscience Corp. has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the USA and in Australia for utilization of its DehydraTECH(TM) delivery technology. Lexaria’s technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. For more information, visit the company’s website at www.LexariaBioscience.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html


Monday, February 25, 2019

MissionIRNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Increases Operating Capacity at Hamilton Facility


Cannabis-focused research and development company the Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) recently issued an update regarding the construction at its Valleyfield, Quebec, and Hamilton, Ontario, facilities. A recent article discussing the company reads, “Regarding the Hamilton operations, TGOD has modified major systems from the original design. Furthermore, the company has re-engineered the whole harvesting process to enhance production uptime and facility throughput. Therefore, this has resulted in increased productive capacity from 14,000 kg to 17,500 kg. TGOD has grown and successfully harvested numerous crops in the pilot facility. It has also stored product for its forthcoming medical pilot launch. . . . In a news release, Brian Athaide, TGOD’s chief executive officer, said, ‘Not only have we addressed the important redesign requirements, we have also made significant improvements to the operating capacity and capital timing of our facilities, resulting in an additional 46,500 kgs of productive capacity.’”

To view the full article, visit http://ibn.fm/vbpz1

About the Green Organic Dutchman Holdings Ltd.

The Green Organic Dutchman Holdings is a publicly traded, premium global organic cannabis company with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. The company grows high-quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned global capacity of 219,000 kgs. and is building 1,643,600 square feet of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark. For more information, visit the company’s website at www.TGOD.ca.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html


Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Plans Additional Clinical Trials Following Successful Tests


  • Company recently announced significant findings of cardiovascular performance improvements with TurboCBD
  • Lexaria plans additional human clinical trials of CBD
  • Company is now moving forward with clinical studies on oral forms of nicotine delivery following a large investment agreement
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is a food bioscience company that developed and commercialized cost-effective drug delivery platform DehydraTECH. This technology enhances the performance of beneficial compounds in ingestible products. Currently, Lexaria has patents pending worldwide for use of the technology in a range of bioactive molecules, including cannabinoids, nicotine, NSAID pain relievers and more. Leveraging this platform, the taste, smell, speed of action, bioabsorption and bioavailability of oral ingestion is improved without the harmful practices of lighting up or the unhealthy additions of sugars and sweeteners. The company licenses DehydraTECH to other companies around the world to enhance already established, quality product lines.

TurboCBD is Lexaria’s proprietary DehydraTECH-powered, CBD-fortified hemp-oil capsule. The capsules are formulated with full-spectrum hemp oil, ginseng and ginkgo for enhanced focus and memory. They are marketed as a mental and physical boost aimed at helping to remove brain fog, fatigue and stress. TurboCBD is molecularly engineered for quick and high absorption rates into the circulatory system.

In a recent press release (http://ibn.fm/OwOtT), Lexaria announced that the results from a healthy-human clinical trial provided evidence that a single 90mg dose of TurboCBD resulted in lower blood pressure, higher blood flow to the brain, faster delivery onset of CBD into the bloodstream and larger quantities of CBD within the blood as compared to an equal dose of generic CBD. Due to the positive results of this study, the company plans to conduct additional human clinical trials over the course of the next year using DehydraTECH in CBD.

A comprehensive series of clinical studies will also continue on oral forms of nicotine delivery. Lexaria Nicotine LLC, a wholly owned subsidiary, has entered into an investment agreement that will provide an initial $1 million, with additional funding of up to $12 million, toward the research and development of nicotine consumer products enhanced by DehydraTECH.

DehydraTECH is an enabling drug-delivery platform with relevance across multiple industries. The company utilizes subsidiaries that reach across industry lines, making it accessible to the medical and recreational cannabis industries and pharmaceutical sectors. The company has formed a partnership with one of the world’s largest tobacco companies (http://ibn.fm/v91xQ). Currently, Lexaria owns 10 patents with over 50 patents pending worldwide for this revolutionary technology. Lexaria is ahead of the game, doing business on its terms and attracting the attention of Fortune 500-type corporations.

For more information, visit the company’s website at www.LexariaBioscience.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html


ChineseInvestors.com Inc.’s (CIIX) ‘opt’ Brand Features opt Hemp and opt2mist Hemp-Derived CBD Lines, Unifies Domestic Products

  • CIIX recently established a new website to present its domestic CBD line and offer consumers one-stop shopping convenience
  • CIIX’s CBD Biotechnology Co. Ltd has a separate line designed for the Chinese market
  • CIIX CEO says that additional opt brand industrial hemp-infused CBD products will be developed and introduced
ChineseInvestors.com Inc. (OTCQB: CIIX) has moved to rebrand subsidiary ChineseHempOil.com Inc.’s consumer products line under the new ‘opt’ brand. The brand unifies its domestic industrial hemp-infused consumer products and features two lines: opt Hemp and opt2mist (http://ibn.fm/7IU4K).
The opt Hemp currently line includes gummies, oils, soft gels and cosmetics. It also consists of other hemp-derived CBD products in development.
The company’s opt2mist is a spray-vitamin line of products in development that will also include full-spectrum, hemp-derived CBD-infused formulas.
In a news release, CIIX CEO Warren Wang stated, “The unification of our domestic consumer products under the opt brand is a step in the right direction to building optimal brand recognition as we continue to roll out our new industrial, hemp-infused CBD products and other health and wellness products, such as the opt2mist sprays, throughout 2019 and beyond.”
CIIX has also set up a new website, www.365CWC.com, to present the products with brand appeal. “The consolidation of our domestic consumer sites into a single channel will provide a one-stop shop for busy consumers, which, in turn, we believe will ultimately drive sales,” Wang added.
CIIX’s wholly owned foreign entity, CBD Biotechnology Co. Ltd., has separate products created for the Chinese market. These include a skin care line featuring the Live Oxygen luxury products and CBD Magic Hemp series, plus its self-branded, hemp-infused rice wine, CBD Biotech Hemp Wine. Live Oxygen and Magic Hemp are featured on e-commerce site Alibaba, which has 500 million registered users.
For more information, visit the company’s website at www.ChineseInvestors.com
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html